# Icatibant

NDC: 63323-574
Generic name: Icatibant
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20201115

FDA application: ANDA208317

## Active ingredients

- ICATIBANT ACETATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-574"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-574
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=52c12c15-c00b-4efc-952d-1425c907706a